Searched for
COVAXIN PAEDIATRIC TRIALS
Cannot sit in judgement of leading scientific analysis on safety of paediatric vaccination, says Supreme CourtThe apex court noted that according to the Union of India, the said data would show that the vaccine does not pose threat to the safety of ...- No individual can be forced to be vaccinated, says SC; "Bodily integrity protected under Constitution"A bench of Justices L Nageswara Rao and B R Gavai said bodily autonomy and integrity are protected under Article 21 of the Constitution. Th...
- Over 180 cr doses of COVID vaccines administered, 77,314 adverse events reported: Centre to SCThe government said that over 8.91 crore doses of vaccine Covaxin has been administered in the age group of 15-18 years as on March 12 and ...
- Number of Omicron cases increasing rapidly, but there is no need to panic: NK Arora Chair, India’s COVID-19 working groupThe purpose of an additional booster dose is for different objectives. Additional doses are usually offered to those who are likely to have...
- Covaxin safe and immunogenic in 2-18 age group, says Bharat BiotechThe Hyderabad-based company had conducted phase-2/3, open-label, and multi-centre studies to evaluate the safety, reactogenicity, and immun...
- Bharat Biotech's partner seeks Covaxin nod in US for children between 2 and 18 yearsThe US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 chi...
- In no hurry, government seeks more opinion on Covaxin for kidsNo country is administering a Covid vaccine to children as young as 2 years. US and UK have introduced vaccines for adolescents between 16 ...
- Doctors welcome expert panel's suggestion on Covaxin for children; flag issue of global acceptanceAn expert panel of India's central drug authority has recommended granting emergency use authorisation to Covaxin for children in the age g...
- Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
- Covid in India maybe entering some kind of stage of endemicity: WHO's Soumya Swaminathan"We may be entering some kind of stage of endemicity where there is low level transmission or moderate level transmission going on but we a...
- ‘Cadila vaccine found to be safe for children aged 12-18 years’The Ahmedabad-based company is carrying out clinical trials involving 1,000 children to test the efficacy of its vaccine against SARS-CoV-2...
- Paediatric trials of Covaxin may begin in June: Bharat Biotech officialThe efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety proto...
- Bharat Biotech set to begin paediatric trials of Covaxin from June“It will be a trial on children aged 2-18 years,” said Raches Ella, Bharat Bio’s head-business development and international advocacy, addr...
- 2 billion Covid jabs to be available between August & December: GovernmentThe new ambitious projections assume significant capacity expansion of the two current vaccine-makers as well as the launch of five new vac...
- India starts vaccinating: No hospitalisation reported, major problems were delay in uploading beneficiary listsSerum Institute of India’s Covishield and Bharat Biotech’s Covaxin were deployed across the country on Saturday. Covaxin was deployed in 11...
- How Krishna Ella built Bharat Biotech and why the company is at a tipping pointBharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...
- Covishield and Covaxin: Key concerns over the two vaccinesET tries to clear some concerns around the development with experts’ views on how the two vaccines can be used for India’s public vaccinati...
- Midwifing the vaccine: The When is visible but there’s much left to do on the Who and HowThe big ‘but’ butts into scalability. The usual sticking point of lab-to-arm is hugely multiplied when dealing with a totally new vaccine a...
Load More
